The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Yourgene to acquire BC BioTech Coastal Genomics for up to $17.9 million CAD (BETAKIT)
Burnaby, British Columbia-based Coastal Genomics, a BioTech engineering startup, is set to be acquired by the UK’s Yourgene Health for up to $17.9 million CAD.
On-demand mental health service provider Ginger raises $50 million (TECHCRUNCH)
Ginger, a provider of on-demand mental healthcare services, has raised $50 million in a new round of funding.
Government in contact with Apple, Google about COVID Alert device compatibility concerns (MOBILESYRUP)
The Canadian government is facing scrutiny for the lack of accessibility when it comes to the app since it requires people use relatively newer devices and operating systems, despite the fact that Apple and Google are behind those requirements.
Virtual care can make all the difference when treating the most vulnerable patients (CBC)
Beyond the pandemic, we need to ensure virtual medicine remains a permanent fixture of health care system.
While venture funding stays consistent, BC startup deal count sees Q1 decline (BETAKIT)
Venture funding in British Columbia reached $246 million over 50 deals in the first quarter of 2020, according to Hockeystick’s latest ecosystem report.
Why providers should address disparities in telehealth access (HEALTHTECH MAGAZINE)
Delivering virtual care to everyone requires adaptation, training and deep insights into issues that can hinder a connection.
Alberta to adopt national COVID-19 tracing app (EDMONTON JOURNAL)
Alberta will adopt the federal government’s COVID-19 notification app after months of struggles with its provincial version.
Canadian tech says continued IRAP IAP funding “critical” to sustaining business amid pandemic (BETAKIT)
Multiple tech leaders have called the NRC IRAP Innovation Assistance Program “critical” to sustaining their own businesses.
Teladoc Health reaches agreement to buy Livongo in a $18.5 billion deal (STAT)
Livongo’s share price is nearly six times higher than it was at the start of 2020, and Teladoc’s has tripled in that period.
Infermedica announces $10.2M series A for triage, symptom checking system (MOBIHEALTHNEWS)
The new round was led by European Bank for Reconstruction and Development and Health Capital.
